Kiepura, A.; Stachyra, K.; Wiśniewska, A.; Kuś, K.; Czepiel, K.; Suski, M.; Ulatowska-Białas, M.; Surmiak, M.; Olszanecki, R.
The Anti-Atherosclerotic Action of FFAR4 Agonist TUG-891 in ApoE–Knockout Mice Is Associated with Increased Macrophage Polarization towards M2 Phenotype. Int. J. Mol. Sci. 2021, 22, 9772.
https://doi.org/10.3390/ijms22189772
AMA Style
Kiepura A, Stachyra K, Wiśniewska A, Kuś K, Czepiel K, Suski M, Ulatowska-Białas M, Surmiak M, Olszanecki R.
The Anti-Atherosclerotic Action of FFAR4 Agonist TUG-891 in ApoE–Knockout Mice Is Associated with Increased Macrophage Polarization towards M2 Phenotype. International Journal of Molecular Sciences. 2021; 22(18):9772.
https://doi.org/10.3390/ijms22189772
Chicago/Turabian Style
Kiepura, Anna, Kamila Stachyra, Anna Wiśniewska, Katarzyna Kuś, Klaudia Czepiel, Maciej Suski, Magdalena Ulatowska-Białas, Marcin Surmiak, and Rafał Olszanecki.
2021. "The Anti-Atherosclerotic Action of FFAR4 Agonist TUG-891 in ApoE–Knockout Mice Is Associated with Increased Macrophage Polarization towards M2 Phenotype" International Journal of Molecular Sciences 22, no. 18: 9772.
https://doi.org/10.3390/ijms22189772
APA Style
Kiepura, A., Stachyra, K., Wiśniewska, A., Kuś, K., Czepiel, K., Suski, M., Ulatowska-Białas, M., Surmiak, M., & Olszanecki, R.
(2021). The Anti-Atherosclerotic Action of FFAR4 Agonist TUG-891 in ApoE–Knockout Mice Is Associated with Increased Macrophage Polarization towards M2 Phenotype. International Journal of Molecular Sciences, 22(18), 9772.
https://doi.org/10.3390/ijms22189772
